[1. Bilimoria KY, Bentrem DJ, Ko CY, Ritchey J, Stewart AK, Winchester DP, Talamonti MS. Validation of the 6th edition AJCC Pancreatic Cancer Staging System: report from the National Cancer Database // Cancer, 2007; 110:738 - 744]Search in Google Scholar
[2. Cleary SP, Gryfe R, Guindi M, Greig P, Smith L, Mackenzie R, Strasberg S, Hanna S, Taylor B, Langer B, Gallinger S. Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors // J Am Coll Surg, 2004; 198:722 -731]Search in Google Scholar
[3. Feldmann G, Dhara S, Fendrich V, Bedja D, Beaty R, Mullendore M, Karikari C, Alvarez H, Iacobuzio- Donahue C, Jimeno A, Gabrielson KL, Matsui W, Maitra A. Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers // Cancer Res, 2007; 67:2187 - 2196]Search in Google Scholar
[4. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D, Bray F. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012 // Eur J Cancer, 2013; 49:1374 - 1403]Search in Google Scholar
[5. Hamidov Z, Altendorf-Hofmann A, Chen Y, Settmacher U, Petersen I, Knösel T. Reduced expression of desmocollin 2 is an independent prognostic biomarker for shorter patients survival in pancreatic ductal adenocarcinoma // J Clin Pathol, 2011; 64:990 - 994]Search in Google Scholar
[6. Handra-Luca A, Hong SM, Walter K, Wolfgang C, Hruban R, Goggins M. Tumour epithelial vimentin expression and outcome of pancreatic ductal adenocarcinomas // Br J Cancer, 2011; 104:1296 -1302]Search in Google Scholar
[7. Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Kamiyama H, Jimeno A, Hong SM, Fu B, Lin MT, Calhoun ES, Kamiyama M, Walter K, Nikolskaya T, Nikolsky Y, Hartigan J, Smith DR, Hidalgo M, Leach SD, Klein AP, Jaffee EM, Goggins M, Maitra A, Iacobuzio- Donahue C, Eshleman JR, Kern SE, Hruban RH, Karchin R, Papadopoulos N, Parmigiani G, Vogelstein B, Velculescu VE, Kinzler KW. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses // Science, 2008; 321:1801 - 1806]Search in Google Scholar
[8. Kaur S, Baine MJ, Jain M, Sasson AR, Batra SK. Early diagnosis of pancreatic cancer: challenges and new developments // Biomark Med, 2012; 6:597 -612]Search in Google Scholar
[9. Kppel G, Hruban RH, Longnecker DS, Adler G, Kern SE, Partanen TJ. Tumours of the exocrine pancreas // Hamilton SR, Aaltonen LA. World Health Organization classification of tumours. Pathology and genetics of tumours of the digestive system. Lyon: IARC; 2000; 219 - 230]Search in Google Scholar
[10. Krantz SB, Shields MA, Dangi-Garimella S, Munshi HG, Bentrem DJ. Contribution of epithelial-tomesenchymal transition and cancer stem cells to pancreatic cancer progression // J Surg Res, 2012; 173:105 - 112]Search in Google Scholar
[11. Lim JE, Chien MW, Earle CC. Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients // Ann Surg, 2003; 237:74 - 85]Search in Google Scholar
[12. Lynch HT, Brand RE, Deters CA, Shaw TG, Lynch JF. Hereditary pancreatic cancer // Pancreatology, 2001; 1:466 - 471]Search in Google Scholar
[13. Macgregor-Das AM, Iacobuzio-Donahue CA. Molecular pathways in pancreatic carcinogenesis // J Surg Oncol, 2013; 107:8 - 14]Search in Google Scholar
[14. McCleary-Wheeler AL, Lomberk GA, Weiss FU, Schneider G, Fabbri M, Poshusta TL, Dusetti NJ, Baumgart S, Iovanna JL, Ellenrieder V, Urrutia R, Fernandez-Zapico ME. Insights into the epigenetic mechanisms controlling pancreatic carcinogenesis // Cancer Lett, 2013; 328:212 - 221]Search in Google Scholar
[15. Momi N, Kaur S, Krishn SR, Batra SK. Discovering the route from inflammation to pancreatic cancer // Minerva Gastroenterol Dietol, 2012; 58:283 - 297]Search in Google Scholar
[16. Niederhuber JE, Brennan MF, Menck HR. The National Cancer Data Base report on pancreatic cancer // Cancer, 1995; 76:1671 - 1677]Search in Google Scholar
[17. Oshima M, Okano K, Muraki S, Haba R, Maeba T, Suzuki Y, Yachida S. Immunohistochemically detected expression of 3 major genes (CDKN2A/p16, TP53, and SMAD4/DPC4) strongly predicts survival in patients with resectable pancreatic cancer // Ann Surg, 2013; 258:336 - 346]Search in Google Scholar
[18. Pannala R, Basu A, Petersen GM, Chari ST. Newonset diabetes: a potential clue to the early diagnosis of pancreatic cancer // Lancet Oncol, 2009; 10:88 -95]Search in Google Scholar
[19. Pavai S, Yap SF. The clinical significance of elevated levels of serum CA 19-9 // Med J Malaysia, 2003; 58:667 - 672]Search in Google Scholar
[20. Poi MJ, Knobloch TJ, Yuan C, Tsai MD, Weghorst CM, Li J. Evidence that P12, a specific variant of P16(INK4A), plays a suppressive role in human pancreatic carcinogenesis // Biochem Biophys Res Commun, 2013, 436:217 - 22210.1016/j.bbrc.2013.05.078375242423727582]Search in Google Scholar
[21. Rohan VS, Hsu JT, Liu KH, Yeh CN, Yeh TS, Jan YY, Hwang TL. Long-term results and prognostic factors in resected pancreatic body and tail adenocarcinomas // J Gastrointest Cancer, 2013; 44:89 - 93]Search in Google Scholar
[22. Rosty C, Geradts J, Sato N, Wilentz RE, Roberts H, Sohn T, Cameron JL, Yeo CJ, Hruban RH, Goggins M. p16 inactivation in pancreatic intraepithelial neoplasias (PanINs) arising in patients with chronic pancreatitis // Am J Surg Pathol, 2003; 27:1495 -1501]Search in Google Scholar
[23. Sato N, Fukushima N, Hruban RH, Goggins M. CpG island methylation profile of pancreatic intraepithelial neoplasia // Mod Pathol, 2008; 21:238 - 244]Search in Google Scholar
[24. Schutte M, Hruban RH, Geradts J, Maynard R, Hilgers W, Rabindran SK, Moskaluk CA, Hahn SA, Schwarte-Waldhoff I, Schmiegel W, Baylin SB, Kern SE, Herman JG. Abrogation of the Rb/p16 tumorsuppressive pathway in virtually all pancreatic carcinomas // Cancer Res, 1997; 57:3126 - 3130]Search in Google Scholar
[25. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012 // CA Cancer J Clin, 2012; 62:10 - 29]Search in Google Scholar
[26. Simtniece Z, Strumfa I, Abolins A, Vanags A, Gardovskis J. Prognostic factors after curative resection of pancreatic ductal adenocarcinoma: a retrospective study // Journal of Cancer Therapeutics & Research, 2012; 1:http://www. hoajonline.com/jctr/2049-7962/1/27#10.7243/2049-7962-1-27]Search in Google Scholar
[27. Takaori K, Hruban RH, Maitra A, Tanigawa N. Current topics on precursors to pancreatic cancer // Adv Med Sci, 2006; 51:23 - 30]Search in Google Scholar
[28. Thayer SP, di Magliano MP, Heiser PW, Nielsen CM, Roberts DJ, Lauwers GY, Qi YP, Gysin S, Fernándezdel Castillo C, Yajnik V, Antoniu B, McMahon M, Warshaw AL, Hebrok M. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis // Nature, 2003; 425:851 - 856]Search in Google Scholar
[29. Tummala P, Junaidi O, Agarwal B. Imaging of pancreatic cancer: an overview // J Gastrointest Oncol, 2011; 2:168 - 174]Search in Google Scholar
[30. Yadav D, Lowenfels AB. The epidemiology of pancreatitis and pancreatic cancer // Gastroenterology, 2013; 144:1252 - 1261 ]Search in Google Scholar